You are here

Novartis Drug Exposure Pregnancy Registry for Female CML Patients

Novartis Oncology, the manufacturer of Gleevec® & Tasigna® has established this Pregnancy Drug Exposure Registry to learn about pregnancy outcomes and the health of women who have taken Gleevec® and/or Tasigna® within six months prior to conception or during pregnancy. The information gathered in this Registry may supplement other sources of data and assist clinicians and patients in weighing the risks or benefits of being exposed to these medications around conception and during pregnancy

See under Essential Reading on the right bottom of this page for a direct link to the registry website.

What a great initiative and the right step forward.

Many young women are now being diagnosed with CML who are asking the question re: having a family and quite a number of women have been successful in their pregnancy with CML.

As more people are being diagnosed with CML because blood testing is becoming more advanced and the community doctors or GP's are blood testing more quickly as a medical tool you would think more young women will be diagnosed early so that decision as to have a family may become a common CML question.

This register will certainly assist clinicians in how to treat pregnancy to successful outcomes more easily.

A young woman in Australia has successfully given birth to a little girl - her situation was quite different to the decision to have a child or not - as she was pregnant when diagnosed with CML. Treated initially with interferon and when given birth then started the glivec medication. The pregnancy was tricky and a shared care management with her CML Specialist and Obstetrician. She is bottle feeding her little girl who is now 10 months old.

It would be another step forward by the drug company for the same type of register for hormone issues associated with glivec - I am sure the feedback would of importance to the drug company and they maybe very surprised at how many women have at hormonal problems from glivec (I do not know if hormone problems are a common side effect with those taking Tasi but glivec I would suggest yes.)

Sandy
Thanks for all the research information you provide - really appreciated and the benefit is that the information can be used to discuss with the CML specialist or GP besides that of general knowledge of the side effects and the condition itself.

Would you mind if I forward the Pregnancy Register information to that of the Australian LF bulletin.

Please advise

Sue

Dear Sue....
please feel free to use the link to share with anyone you feel would benefit.

The more doctors that use it to register CML patients who have become pregnant whilst taking Glivec the better our understanding of the potential risks.
This registry is for doctors to use... so it would be helpful to the global community if as many as possible are made aware of its existance.

I will take on board your comments about the possible hormone effects for women on Glivec therapy. I will do my best to get this on the 'agenda'... although, like the pregnancy registry it might take some time ;o)

Sandy

Thanks Sandy

Your support of all of us is appreciated

A Hormone Register - now that would be a positive benefit

I would not like another CML person to go thru what I went
thru with a bleed out, so if a register to could assist
medicos and cml community alike that would be also be cost effective in ease treatment streams - infusions, transfusions, surgery, hospital time etc

Sue